{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:15:42Z","timestamp":1770480942793,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T00:00:00Z","timestamp":1190073600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s10067-007-0733-8","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T03:51:35Z","timestamp":1190001095000},"page":"2205-2206","source":"Crossref","is-referenced-by-count":28,"title":["Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis"],"prefix":"10.1007","volume":"26","author":[{"given":"K.","family":"Vandevyvere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. P.","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Verschueren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Lories","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Segaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Westhovens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,18]]},"reference":[{"issue":"2","key":"733_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1067\/mjd.2003.228","volume":"48","author":"L Mallbris","year":"2003","unstructured":"Mallbris L, Ljungberg A, Hedblad MA et al (2003) Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol 48(2):290\u2013293","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"733_CR2","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1001\/archderm.140.8.919","volume":"140","author":"BT Kovach","year":"2004","unstructured":"Kovach BT, Calamia KT, Walsh JS, Ginsburg WW (2004) Treatment of multicentric reticulohistiocytosis with etanercept. Arch Dermatol 140(8):919\u2013921","journal-title":"Arch Dermatol"},{"issue":"1","key":"733_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1067\/mjd.2001.119100","volume":"46","author":"C Sacher","year":"2002","unstructured":"Sacher C, Rubbert A, Konig C et al (2002) Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept. J Am Acad Dermatol 46(1):113\u2013115","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"733_CR4","first-page":"930","volume":"137","author":"MH Tan","year":"2001","unstructured":"Tan MH, Gordon M, Lebwohl O et al (2001) Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 137(7):930\u2013933","journal-title":"Arch Dermatol"},{"issue":"2","key":"733_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2230.2004.01681.x","volume":"30","author":"VJ Swale","year":"2005","unstructured":"Swale VJ, Saha M, Kapur N et al (2005) Pyoderma gangrenosum outside the context of inflammatory bowel disease treated successfully with infliximab. Clin Exp Dermatol 30(2):134\u2013136","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"733_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2230.2004.01470.x","volume":"29","author":"M Singh","year":"2004","unstructured":"Singh M, Andrew SM, Lear JT (2004) Infliximab as a treatment for recalcitrant pyoderma gangrenosum. Clin Exp Dermatol 29(2):196\u2013197","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"733_CR7","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","volume":"98","author":"M Regueiro","year":"2003","unstructured":"Regueiro M, Valentine J, Plevy S et al (2003) Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 98(8):1821\u20131826","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"733_CR8","first-page":"258","volume":"13","author":"A Zaccagna","year":"2003","unstructured":"Zaccagna A, Bertone A, Puiatti P et al (2003) Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn\u2019s disease. Eur J Dermatol 13(3):258\u2013260","journal-title":"Eur J Dermatol"},{"issue":"9","key":"733_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1080\/003655202320378338","volume":"37","author":"T Ljung","year":"2002","unstructured":"Ljung T, Staun M, Grove O et al (2002) Pyoderma gangrenosum associated with Crohn disease: effect of TNF-(alpha) blockade with infliximab. Scand J Gastroenterol 37(9):1108\u20131110","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"733_CR10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/gut.2005.074815","volume":"55","author":"TN Brooklyn","year":"2006","unstructured":"Brooklyn TN, Dunnill MG, Shetty A et al (2006) Infliximab for treatment of pyoderma gangrenosum: a randomized, double blind placebo controlled trial. Gut 55(4):505\u2013509","journal-title":"Gut"},{"key":"733_CR11","first-page":"e8","volume":"5","author":"MA Fonder","year":"2006","unstructured":"Fonder MA, Cummins DL, Ehst BD et al (2006) Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 5:e8","journal-title":"J Burns Wounds"},{"issue":"3","key":"733_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/jlb.41.3.196","volume":"41","author":"MR Shalaby","year":"1987","unstructured":"Shalaby MR, Palladino MA, Hirabayashi SE et al (1987) Receptor-binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J Leukoc Biol 41(3):196\u2013204","journal-title":"J Leukoc Biol"},{"issue":"1","key":"733_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1046\/j.1365-2230.2000.00575.x","volume":"25","author":"L Skov","year":"2000","unstructured":"Skov L, Baadsgaard O (2000) Bacterial superantigens and inflammatory skin diseases. Clin Exp Dermatol 25(1):57\u201361","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"733_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/art.1780370505","volume":"37","author":"M Kloppenburg","year":"1994","unstructured":"Kloppenburg M, Breedveld FC, Terwiel JP et al (1994) Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum 37(5):629\u2013636","journal-title":"Arthritis Rheum"},{"issue":"12","key":"733_CR15","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/ard.2006.059261","volume":"65","author":"C Ritchlin","year":"2006","unstructured":"Ritchlin C, Tausk F (2006) A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents. Ann Rheum Dis 65(12):1541\u20131544","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-007-0733-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0733-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-007-0733-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T04:51:09Z","timestamp":1559105469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-007-0733-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,18]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["733"],"URL":"https:\/\/doi.org\/10.1007\/s10067-007-0733-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,18]]}}}